Stay updated on Surufatinib in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Advanced Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record describes a completed Phase 1/2 study evaluating surufatinib in patients with advanced solid tumors, including its treatment arms, eligibility criteria, locations, and outcome measures. It also includes posted study results and supporting documents.
    Difference
    69%
    Check dated 2026-11-08T13:44:28.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:08:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” in federal agency content, with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:43:55.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The study page still shows a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T15:11:59.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error, with the footer revision changing from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:59:54.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The Study Record page now renders a 403 Forbidden error, blocking access to the study details and related documents.
    Difference
    21%
    Check dated 2026-09-20T19:44:09.000Z thumbnail image

Stay in the know with updates to Surufatinib in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.